|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| A multicenter clinical trial of a progestin-only oral contraceptive in |
| Dunson TR; McLaurin VL; Grubb GS; Rosman AW |
| CONTRACEPTION. 1993 Jan;47(1):23-35. |
| A noncomparative study of a progestin-only oral contraceptive (POC) containing 75 mcg norgestrel was conducted at |
| 22 sites in 14 countries. This study was designed to evaluate safety, contraceptive efficacy, and the overall |
| acceptability of a POC in breast feeding women. A total of 4088 women entered the study over a 3-year period and |
| 29,399 women-months of experience were gathered. Women had follow-up visits at 2, 6, and 11 months after |
| admission. Headaches and vaginal discharge were the medical complaints most commonly reported by women, |
| both prior to and after admission. Menstrual problems were reported by 59% of the women after admission. Of the |
| 3714 women who returned for at least 1 follow-up visit, 1101 (29.6%) discontinued through month 11. The 11-month |
| total discontinuation percentage, including those lost to follow-up (25.3%) was 51.6%. The most common reason |
| given for discontinuation was a women's desire for a change in contraceptive method. Only 4.9% discontinued pill |
| use for menstrual problems, a percentage far below those generally reported for POCs. 29 unintended pregnancies |
| occurred through 11 months giving a gross cumulative life table rate of 1.2/100 women (Pearl Index = 1.4). The POC |
| appears to be a safe, effective and acceptable contraceptive option for postpartum breastfeeding women. |
| (PubHealth.info Document ID: CONT2T 4555-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "A multicenter clinical trial of a progestin-only oral |
| contraceptive in lactating women.", is(are) Dunson TR; McLaurin VL; Grubb GS; Rosman AW. The source of this |
| article is "CONTRACEPTION. 1993 Jan;47(1):23-35.". This article was published in 1993 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 4555-06. All rights reserved with PubHealth.info) PIN: 9555 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
